EGFR amplification and lack of activating mutations in metaplastic breast carcinomas - Wikidata - awgldk - TriplyDB

EGFR amplification and lack of activating mutations in metaplastic breast carcinomas

EGFR amplification and lack of activating mutations in metaplastic breast carcinomas

http://www.wikidata.org/entity/Q57713522

about

Biomarkers in triple negative breast cancer: A review Metaplastic breast cancer: histologic characteristics, prognostic factors and systemic treatment strategies.Selective regain of egfr gene copies in CD44+/CD24-/low breast cancer cellular model MDA-MB-468.The Role of FGFR1 Gene Amplification as a Poor Prognostic Factor in Squamous Cell Lung Cancer: A Meta-Analysis of Published Data Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma.Suicide HSVtk gene delivery by neurotensin-polyplex nanoparticles via the bloodstream and GCV Treatment specifically inhibit the growth of human MDA-MB-231 triple negative breast cancer tumors xenografted in athymic mice.Prognostic Evaluation of Epidermal Growth Factor Receptor (EGFR) Genotype and Phenotype Parameters in Triple-negative Breast Cancers.β-catenin/Wnt signalling pathway in fibromatosis, metaplastic carcinomas and phyllodes tumours of the breast.Triple-negative breast cancer: the importance of molecular and histologic subtyping, and recognition of low-grade variants.Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention.Metaplastic carcinoma of the breast: an immunohistochemical study Silencing kinase-interacting stathmin gene enhances erlotinib sensitivity by inhibiting Ser¹⁰ p27 phosphorylation in epidermal growth factor receptor-expressing breast cancer.Correlation of tumor-infiltrating lymphocytes to histopathological features and molecular phenotypes in canine mammary carcinoma: A morphologic and immunohistochemical morphometric study High levels of dietary soy decrease mammary tumor latency and increase incidence in MTB-IGFIR transgenic mice Fibromatosis-like metaplastic carcinoma of the breast has a claudin-low immunohistochemical phenotype.Triple-negative breast cancer with brain metastases: a comparison between basal-like and non-basal-like biological subtypes.Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy.Dual inhibition of EGFR and MET induces synthetic lethality in triple-negative breast cancer cells through downregulation of ribosomal protein S6 The epidermal growth factor receptor (EGFR / HER-1) gatekeeper mutation T790M is present in European patients with early breast cancer.FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis.Lack of EGFR-activating mutations in European patients with triple-negative breast cancer could emphasise geographic and ethnic variations in breast cancer mutation profiles Epidermal growth factor receptor status in anaplastic thyroid carcinoma.Demystifying basal-like breast carcinomas Management of unusual histological types of breast cancer.An essential role of metalloprotease-disintegrin ADAM12 in triple-negative breast cancer Combination genetic signature stratifies lower-grade gliomas better than histological grade.Detection of ALK fusion transcripts in FFPE lung cancer samples by NanoString technology Inhibition of triple-negative breast cancer models by combinations of antibodies to EGFR.Immunotherapy of cancer: from monoclonal to oligoclonal cocktails of anti-cancer antibodies: IUPHAR Review 18.Anticipatory activation of the unfolded protein response by epidermal growth factor is required for immediate early gene expression and cell proliferation.Prognostic factors in the myoepithelial-like spindle cell type of metaplastic breast cancer EGFR/HER2 in breast cancer: a biological approach for molecular diagnosis and therapy.VEGF-D expression correlates with colorectal cancer aggressiveness and is downregulated by cetuximab.Role of epidermal growth factor receptor in breast cancer.Molecular analysis of metaplastic breast carcinoma: high EGFR copy number via aneusomy Lapatinib-loaded human serum albumin nanoparticles for the prevention and treatment of triple-negative breast cancer metastasis to the brain.Metaplastic breast cancer with rapidly progressive recurrence in a young woman: case report and review of the literature.Analysis of a synchronous gliosarcoma and meningioma with long survival: A case report and review of the literature.Triple negative breast carcinoma EGFR amplification is not associated with EGFR, Kras or ALK mutations ctDNA dynamics: a novel indicator to track resistance in metastatic breast cancer treated with anti-HER2 therapy

P2860

Q26775094-4D602F9D-9222-4675-B8CA-D407F128B99A Q30447049-7789E2A4-5314-4D6D-A539-E80027EC5304 Q30978860-213649C6-DF13-4C33-8E4C-AF268A286172 Q31038314-43F5D8F9-9A07-4EE7-8152-9BA176372927 Q33475963-308AEB44-73F4-4B17-B97C-53CA1161A096 Q33604560-33A7B0E0-7A25-4036-A472-3360520BBE84 Q33646271-CD163DC1-EE99-4E1F-B656-DC7E2D9B8ABF Q33652448-851D092A-110E-4B67-840E-5DE89BBB4C12 Q33915057-944C55A1-A1D8-41C6-9590-05B805701ABD Q34103963-DEFD42FE-F6C1-4CD3-95E4-75F611644F57 Q34468034-EF2431DB-F64C-492B-AAAD-83B492BE1328 Q34711378-3AC8059E-575E-4BE5-9BC7-05C730EC545B Q35003157-5399BE03-5305-4509-AB21-A5866C79A603 Q35073708-396519EF-6044-4CF7-B9AB-B84719327653 Q35182598-22457D00-7D89-4B05-A653-6961E1FB238F Q35549438-16596E54-A1A5-4B32-A91A-0EE09EF4C54A Q35558988-6FEFA09E-7551-4255-848D-645ABE240CC5 Q35625440-5AFB09F6-7E86-48F3-8EF5-BE36DA390636 Q35744220-462045CE-92D1-418E-B295-F92C77A736F7 Q35794378-9AF99BFE-1EA7-4ABC-B512-376E35ECBC2F Q35889673-0F2ECEBE-178B-4E12-BCF3-C6C98382C430 Q36014238-249BAA9D-B337-4350-87AF-082FDB9EEC5A Q36172507-94762C44-60F4-4959-850B-CD2E06BA2FEE Q36251444-55469377-487E-4932-B979-6F67496FEC27 Q36315707-2EB3BB63-D113-41DD-A91E-EF29B053B95E Q36356194-D14DDDA3-B3DF-430F-A9AD-4D85364C5C03 Q36383083-DF3F4D06-6D37-42A3-A32D-549816BFD536 Q36583011-DD268CE1-EF49-4938-AA87-7D6DC992C696 Q36797398-2E9F0AB6-8C9E-448E-B398-CBEDDB89A923 Q37033459-0F98FB55-6012-4DD9-9AD6-4AC2BA548B87 Q37162623-CBE123ED-10FE-4E7E-8475-2355CAAE871E Q37206247-C0F838DD-A885-40AE-BE92-5F8C5B83B2C9 Q37301478-92AED310-F7DA-4BA8-A12B-C4B2F3763354 Q37320346-66368CA7-920A-4BE5-864F-C9D5DE10F4BB Q37350516-21623992-92F7-4D21-BB85-506F0C273D6A Q37376191-7D8BC7AA-351C-4087-8450-4EEF1A4B2AEC Q37412701-F1AECB29-466C-4ACD-9D5B-E51D031BBB22 Q37413877-C0F60943-F2E2-4ACB-A19B-4B5C25B26FBD Q37594358-891F50CB-0329-4D9D-A089-8E1564B26A45 Q37662351-AE327FE4-72E1-4141-9A61-871738D552E1

P2860

EGFR amplification and lack of activating mutations in metaplastic breast carcinomas

http://www.wikidata.org/entity/Q57713522

description

article

@en

im Januar 2006 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2006

@uk

name

EGFR amplification and lack of activating mutations in metaplastic breast carcinomas

@en

EGFR amplification and lack of activating mutations in metaplastic breast carcinomas

@nl

type

label

EGFR amplification and lack of activating mutations in metaplastic breast carcinomas

@en

EGFR amplification and lack of activating mutations in metaplastic breast carcinomas

@nl

prefLabel

EGFR amplification and lack of activating mutations in metaplastic breast carcinomas

@en

EGFR amplification and lack of activating mutations in metaplastic breast carcinomas

@nl

P1433

Q57713522-7663896C-E315-4CB2-BC23-83A977452772

P1476

Q57713522-CC8D50A7-70F9-4C77-BC7C-D1B9EB9F4FE9

P2093

Q57713522-13FE1F07-8B07-4B2E-A1A0-E249961A3A0F

Q57713522-27710979-6BD5-42EE-A37F-47729CA8DAFB

Q57713522-3E19C8C0-770F-4AE9-85A1-EA2B3C52C09C

Q57713522-45E3D94B-A736-49C0-9BB5-8BDEE7041709

Q57713522-705417D3-12A5-4907-8DFE-20FB6D7DA07B

Q57713522-7B90D353-0900-45B0-A504-35D1427D66EA

Q57713522-7DF12CC6-57E3-4724-A08C-2D91713E1048

Q57713522-98962379-0A7E-4A6A-B189-CE61604471B4

Q57713522-CF7CAE7F-B9DE-4AEF-A3BD-400A0D915C78

Q57713522-D74DEA1C-EE6E-4A76-956E-CA5B8492A54C

P2860

Q57713522-8F30B185-B56D-4845-BA13-BF5630E637EC

Q57713522-E79FED87-8E93-403A-A114-18CDED292C1E

P304

Q57713522-2E4CD9F3-2853-4E82-8C82-5AD768F8B955

P31

Q57713522-C75266CD-EF03-435D-B271-34466D732EFA

P356

Q57713522-0E588FF2-5C22-459C-A81F-56FC0B722AA1

P433

Q57713522-47689E37-F101-4D47-9F21-AAEE4FF74E1B

P478

Q57713522-61A7F44B-554B-4717-90D7-E8897D0AE95B

P50

Q57713522-17F1891E-E6F5-4A39-A371-035A190FE2C7

Q57713522-4EBC40CD-B810-4C48-B12B-B99C6C2DE3A6

Q57713522-5C42C523-15C3-472B-ADB3-AC8256ECB313

Q57713522-61EE05A4-D9CF-4299-94A4-DD6CE40A66B7

Q57713522-8BD7C32B-D4B6-4940-B567-792AA0488A87

Q57713522-90BE4100-029F-47FC-8DEA-213D4B21636E

Q57713522-BD9A4405-401B-49E2-A3E6-2D095CDBE09F

Q57713522-D68D48A3-0579-45D7-A0A0-59AB1FEBA12C

P577

Q57713522-62B3C303-0E00-4F62-B42D-00893DCF1C83

P698

Q57713522-C3943695-D0A2-45EF-B799-AEC23FD1E15C

P356

P1433

The Journal of Pathology

P1476

EGFR amplification and lack of activating mutations in metaplastic breast carcinomas

@en

P2093

Ashworth A

http://www.w3.org/2001/XMLSchema#string

Carvalho S

http://www.w3.org/2001/XMLSchema#string

Fletcher CD

http://www.w3.org/2001/XMLSchema#string

Lambros MB

http://www.w3.org/2001/XMLSchema#string

Mackay A

http://www.w3.org/2001/XMLSchema#string

Milanezi F

http://www.w3.org/2001/XMLSchema#string

Pereira EM

http://www.w3.org/2001/XMLSchema#string

Pinheiro C

http://www.w3.org/2001/XMLSchema#string

Reis-Filho JS

http://www.w3.org/2001/XMLSchema#string

Savage K

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic value of 1p, 19q, 9p, 10q, and EGFR-FISH analyses in recurrent oligodendrogliomas.

Biomarkers to predict response to epidermal growth factor receptor inhibitors.

P304

445-453

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PATH.2004

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

209

http://www.w3.org/2001/XMLSchema#string

P50

Fernando Schmitt

Jason L. Hornick

Peter T. Simpson

Rui Manuel Reis

Fatima Baltazar

Sunil R Lakhani

P577

2006-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16739104

http://www.w3.org/2001/XMLSchema#string